ClinicalTrialsFinder

Human Immunodeficiency Virus (HIV) Infection Clinical Trials in Cape Town, Western Cape

1 recruitingCape Town, Western Cape, South Africa

Showing 1–1 of 1 trials

Recruiting
Phase 2

Doravirine (DOR) in Human Immunodeficiency Virus (HIV)-Infected Children Aged 4 Weeks to <12 Years and <45 kg (MK-1439-066)

Human Immunodeficiency Virus (HIV) Infection
Merck Sharp & Dohme LLC84 enrolled24 locationsNCT04375800